1. Protease-activated receptor 2 enhances renal cell carcinoma cell invasion and migration via PI3K/AKT signaling pathway
   Zhixia Sun et al, 2015, Experimental and Molecular Pathology CrossRef
2. Synthetic Indolactam V Analogues as Inhibitors of PAR2-Induced Calcium Mobilization in Triple-Negative Breast Cancer Cells
   Jan Stein et al, 2018, ChemMedChem CrossRef
3. PAR-2 promotes cell proliferation, migration, and invasion through activating PI3K/AKT signaling pathway in oral squamous cell carcinoma
   Kai-Liang Tang et al, 2019, Biosci. Rep. CrossRef
4. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells
   Yuhong Jiang et al, 2018, J Pharmacol Exp Ther CrossRef
5. Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
   Marek Z. Wojtukiewicz et al, 2015, Cancer Metastasis Rev CrossRef
6. Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis
   Kjetil Søreide et al, 2020, Journal of Pancreatic Cancer CrossRef
7. Mast Cells and Proteins Related to Myofibroblast Differentiation (PAR-2, IL-6, and TGFβ1) in Salivary Cancers: A Preliminary Study
   Adna B. Ismerim et al, 2021 CrossRef
8. PAR2: The Cornerstone of Pancreatic Diseases
   P SUHAJ et al, 2022, Physiol Res CrossRef
9. Edoxaban, a Factor Xa-Specific Direct Oral Anticoagulant, Significantly Suppresses Tumor Growth in Colorectal Cancer Colon26-Inoculated BALB/c Mice
   Keiichi Hiramoto et al, 2023, TH Open CrossRef
10. Upamostat: a serine protease inhibitor for antiviral, gastrointestinal and anticancer indications
    TF. Plasse et al, 2023, Expert Opinion on Investigational Drugs CrossRef
11. Tissue factor signalling modifies the expression and regulation of G1/S checkpoint regulators: Implications during injury and prolonged inflammation
    Sophie Featherby et al, 2024, Mol Med Rep CrossRef